IRON TRIANGLE PARTNERS LP Holdings

IRON TRIANGLE PARTNERS LP is an investment fund managing more than 572.02M US dollars. The largest holdings include Charles River Laboratories International, CIGNA CORP NEW and Neurocrine Biosciences. In Q3 2022 the fund bought assets of total value of 237.05M US dollars and sold assets of total value of 285.35M US dollars.

$572.01M

portfolio value

-0.44%

quarter

-45.29%

1 year

IRON TRIANGLE PARTNERS LP portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q1 2020	95324000	199141000
Q2 2020	178068000	57121000
Q3 2020	130737000	80519000
Q4 2020	391583000	138228000
Q1 2021	277538000	211191000
Q2 2021	469391000	282764000
Q3 2021	226053000	500088000
Q4 2021	283983000	263033000
Q1 2022	301638000	178571000
Q2 2022	295525000	516010000
Q3 2022	237054000	285348000

IRON TRIANGLE PARTNERS LP 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Diagnostics & Research Charles River Laboratories International, Inc. Portfolio share: 6.95% Portfolio value: 39.75M Avg. open price: $270.73 Current price: $215.11 P/L: -20.54% N/A Q3 2022	share	6.95%	39.75M	$270.73	$215.11	-20.54%	N/A Q3 2022
Healthcare Plans CIGNA CORP NEW Portfolio share: 6.94% Portfolio value: 39.68M Avg. open price: $263.52 Current price: $327.39 P/L: +24.24% Bought +78.76% shares Q3 2022	share	6.94%	39.68M	$263.52	$327.39	+24.24%	Bought +78.76% shares Q3 2022
Drug Manufacturers—Specialty & Generic Neurocrine Biosciences, Inc. Portfolio share: 6.60% Portfolio value: 37.76M Avg. open price: $97.48 Current price: $124 P/L: +27.21% Bought +1.60% shares Q3 2022	share	6.60%	37.76M	$97.48	$124	+27.21%	Bought +1.60% shares Q3 2022
Drug Manufacturers—General Sanofi Portfolio share: 5.98% Portfolio value: 34.21M Avg. open price: N/A Current price: $44.93 P/L: N/A N/A Q3 2022	share	5.98%	34.21M	N/A	$44.93	N/A	N/A Q3 2022
Health Information Services HealthEquity, Inc. Portfolio share: 5.17% Portfolio value: 29.55M Avg. open price: N/A Current price: $67.73 P/L: N/A Sold -9.38% shares Q3 2022	share	5.17%	29.55M	N/A	$67.73	N/A	Sold -9.38% shares Q3 2022
Medical Care Facilities Acadia Healthcare Company, Inc. Portfolio share: 4.78% Portfolio value: 27.36M Avg. open price: $64.01 Current price: $85.65 P/L: +33.80% Sold -36.36% shares Q3 2022	share	4.78%	27.36M	$64.01	$85.65	+33.80%	Sold -36.36% shares Q3 2022
Medical Devices Boston Scientific Corporation Portfolio share: 4.74% Portfolio value: 27.11M Avg. open price: N/A Current price: $45.42 P/L: N/A Sold -30.00% shares Q3 2022	share	4.74%	27.11M	N/A	$45.42	N/A	Sold -30.00% shares Q3 2022
Diagnostics & Research Guardant Health, Inc. Portfolio share: 4.58% Portfolio value: 26.22M Avg. open price: $105.61 Current price: $51.95 P/L: -50.81% Sold -50.82% shares Q3 2022	share	4.58%	26.22M	$105.61	$51.95	-50.81%	Sold -50.82% shares Q3 2022
Medical Care Facilities HCA Healthcare, Inc. Portfolio share: 4.50% Portfolio value: 25.73M Avg. open price: N/A Current price: $235.35 P/L: N/A N/A Q3 2022	share	4.50%	25.73M	N/A	$235.35	N/A	N/A Q3 2022
Medical Devices Inari Medical, Inc. Portfolio share: 3.81% Portfolio value: 21.79M Avg. open price: N/A Current price: $71.11 P/L: N/A N/A Q3 2022	share	3.81%	21.79M	N/A	$71.11	N/A	N/A Q3 2022
Medical Devices Bio-Rad Laboratories, Inc. Portfolio share: 3.65% Portfolio value: 20.85M Avg. open price: N/A Current price: $405.79 P/L: N/A Sold -13.73% shares Q3 2022	share	3.65%	20.85M	N/A	$405.79	N/A	Sold -13.73% shares Q3 2022
Medical Instruments & Supplies Repligen Corporation Portfolio share: 3.27% Portfolio value: 18.71M Avg. open price: N/A Current price: $178.61 P/L: N/A Sold -60.00% shares Q3 2022	share	3.27%	18.71M	N/A	$178.61	N/A	Sold -60.00% shares Q3 2022
Medical Devices Insulet Corporation Portfolio share: 3.21% Portfolio value: 18.35M Avg. open price: N/A Current price: $302.43 P/L: N/A N/A Q3 2022	share	3.21%	18.35M	N/A	$302.43	N/A	N/A Q3 2022
Drug Manufacturers—Specialty & Generic Catalent, Inc. Portfolio share: 3.16% Portfolio value: 18.09M Avg. open price: $100.92 Current price: $50.77 P/L: -49.70% N/A Q3 2022	share	3.16%	18.09M	$100.92	$50.77	-49.70%	N/A Q3 2022
Medical Devices Inspire Medical Systems, Inc. Portfolio share: 3.10% Portfolio value: 17.73M Avg. open price: N/A Current price: $234.96 P/L: N/A Sold -12.23% shares Q3 2022	share	3.10%	17.73M	N/A	$234.96	N/A	Sold -12.23% shares Q3 2022
Medical Devices Establishment Labs Holdings Inc. Portfolio share: 3.08% Portfolio value: 17.6M Avg. open price: N/A Current price: $68.77 P/L: N/A Sold -0.84% shares Q3 2022	share	3.08%	17.6M	N/A	$68.77	N/A	Sold -0.84% shares Q3 2022
Medical Devices Pacific Biosciences of California, Inc. Portfolio share: 3.04% Portfolio value: 17.41M Avg. open price: $27.63 Current price: $10.03 P/L: -63.70% N/A Q3 2022	share	3.04%	17.41M	$27.63	$10.03	-63.70%	N/A Q3 2022
Healthcare Plans Humana Inc. Portfolio share: 2.97% Portfolio value: 16.98M Avg. open price: N/A Current price: $547.42 P/L: N/A Sold -65.00% shares Q3 2022	share	2.97%	16.98M	N/A	$547.42	N/A	Sold -65.00% shares Q3 2022
Biotechnology Sarepta Therapeutics, Inc. Portfolio share: 2.90% Portfolio value: 16.58M Avg. open price: N/A Current price: $122.96 P/L: N/A N/A Q3 2022	share	2.90%	16.58M	N/A	$122.96	N/A	N/A Q3 2022
Drug Manufacturers—General Horizon Therapeutics Public Limited Company Portfolio share: 2.87% Portfolio value: 16.40M Avg. open price: $89.51 Current price: $98.48 P/L: +10.02% Bought +76.72% shares Q3 2022	share	2.87%	16.40M	$89.51	$98.48	+10.02%	Bought +76.72% shares Q3 2022
Biotechnology Alnylam Pharmaceuticals, Inc. Portfolio share: 2.80% Portfolio value: 16.01M Avg. open price: N/A Current price: $226.4 P/L: N/A N/A Q3 2022	share	2.80%	16.01M	N/A	$226.4	N/A	N/A Q3 2022
Diagnostics & Research ICON Public Limited Company Portfolio share: 2.69% Portfolio value: 15.4M Avg. open price: $286.5 Current price: $204.76 P/L: -28.53% Sold -47.63% shares Q3 2022	share	2.69%	15.4M	$286.5	$204.76	-28.53%	Sold -47.63% shares Q3 2022
Medical Devices 908 Devices Inc. Portfolio share: 2.59% Portfolio value: 14.80M Avg. open price: $19.43 Current price: $9.4 P/L: -51.63% Bought +5.88% shares Q3 2022	share	2.59%	14.80M	$19.43	$9.4	-51.63%	Bought +5.88% shares Q3 2022
Medical Care Facilities Surgery Partners, Inc. Portfolio share: 2.25% Portfolio value: 12.87M Avg. open price: $24.23 Current price: $28.6 P/L: +18.05% Bought +105.09% shares Q3 2022	share	2.25%	12.87M	$24.23	$28.6	+18.05%	Bought +105.09% shares Q3 2022
Medical Devices DexCom, Inc. Portfolio share: 2.11% Portfolio value: 12.08M Avg. open price: $511.6 Current price: $116.56 P/L: -77.22% Sold -70.00% shares Q3 2022	share	2.11%	12.08M	$511.6	$116.56	-77.22%	Sold -70.00% shares Q3 2022
Shell Companies Orion Acquisition Corp. Portfolio share: 1.72% Portfolio value: 9.86M Avg. open price: $9.92 Current price: $10.08 P/L: +1.56% Sold -0.67% shares Q1 2022	share	1.72%	9.86M	$9.92	$10.08	+1.56%	Sold -0.67% shares Q1 2022
Medical Instruments & Supplies Stereotaxis, Inc. Portfolio share: 0.53% Portfolio value: 3.05M Avg. open price: $9.64 Current price: $2.23 P/L: -76.87% Sold -0.59% shares Q3 2022	share	0.53%	3.05M	$9.64	$2.23	-76.87%	Sold -0.59% shares Q3 2022
Medical Devices CONMED Corporation Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $135.78 Current price: $89.03 P/L: -34.43% Sold -100.00% shares Q3 2022	share	0.00%	0	$135.78	$89.03	-34.43%	Sold -100.00% shares Q3 2022
Drug Manufacturers—General AstraZeneca PLC Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $66.34 Current price: $68.42 P/L: +3.14% Sold -100.00% shares Q3 2022	share	0.00%	0	$66.34	$68.42	+3.14%	Sold -100.00% shares Q3 2022
Drug Manufacturers—General AbbVie Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $122.99 Current price: $163.96 P/L: +33.31% Sold -100.00% shares Q3 2022	share	0.00%	0	$122.99	$163.96	+33.31%	Sold -100.00% shares Q3 2022
Biotechnology Legend Biotech Corporation Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $50.99 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$50.99	N/A	Sold -100.00% shares Q3 2022
SPDR S&P 500 ETF Trust Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $400.01 P/L: N/A Sold -100.00% shares Q3 2022	put	0.00%	0	N/A	$400.01	N/A	Sold -100.00% shares Q3 2022
Biotechnology Karyopharm Therapeutics Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $5.23 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$5.23	N/A	Sold -100.00% shares Q3 2022
Health Information Services SomaLogic, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $12.14 Current price: $2.7 P/L: -77.76% Sold -100.00% shares Q3 2022	share	0.00%	0	$12.14	$2.7	-77.76%	Sold -100.00% shares Q3 2022

Showing TOP 34 IRON TRIANGLE PARTNERS LP's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of IRON TRIANGLE PARTNERS LP?

The biggest position of the IRON TRIANGLE PARTNERS LP is Charles River Laboratories International, Inc. (CRL) with 6.95% portfolio share worth of 39.75M US dollars.

Top 5 IRON TRIANGLE PARTNERS LP's holdings represent 31.64% of the portfolio:

Charles River Laboratories International, Inc. (CRL) – 6.95%
CIGNA CORP NEW (CI) – 6.94%
Neurocrine Biosciences, Inc. (NBIX) – 6.6%
Sanofi (SNY) – 5.98%
HealthEquity, Inc. (HQY) – 5.17%

Who is the portfolio manager of IRON TRIANGLE PARTNERS LP?

The portfolio manager of the IRON TRIANGLE PARTNERS LP is .

What is the total asset value of the IRON TRIANGLE PARTNERS LP portfolio?

IRON TRIANGLE PARTNERS LP total asset value (portfolio value) is 572.02M US dollars.

Who is ?

is the portfolio manager of the IRON TRIANGLE PARTNERS LP.

What is (IRON TRIANGLE PARTNERS LP) fund performance?

IRON TRIANGLE PARTNERS LP's quarterly performance is -0.44%, annualy -45.29%.

What is the IRON TRIANGLE PARTNERS LP CIK?

IRON TRIANGLE PARTNERS LP's Central Index Key is 0001779763 .